Literature DB >> 22241617

Pyrazinamide: a frontline drug used for tuberculosis. Molecular mechanism of action resolved after 50 years?

Alvin S Kalinda1, Courtney C Aldrich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22241617     DOI： 10.1002/cmdc.201100587

Source DB:  PubMed          Journal:  ChemMedChem        ISSN： 1860-7179            Impact factor:   3.466


× No keyword cloud information.
  6 in total

1.  Characterization of extensively drug-resistant Mycobacterium tuberculosis isolates circulating in Siberia.

Authors:  Maya A Dymova; Andrey G Cherednichenko; Olga I Alkhovik; Eugeny A Khrapov; Tatjana I Petrenko; Maxim L Filipenko
Journal:  BMC Infect Dis       Date:  2014-09-03       Impact factor: 3.090

2.  Combined Whole-Cell High-Throughput Functional Screening for Identification of New Nicotinamidases/Pyrazinamidases in Metagenomic/Polygenomic Libraries.

Authors:  Rubén Zapata-Pérez; Antonio G García-Saura; Mohamed Jebbar; Peter N Golyshin; Álvaro Sánchez-Ferrer
Journal:  Front Microbiol       Date:  2016-11-29       Impact factor: 5.640

3.  3-Substituted N-Benzylpyrazine-2-carboxamide Derivatives: Synthesis, Antimycobacterial and Antibacterial Evaluation.

Authors:  Lucia Semelková; Ondřej Janďourek; Klára Konečná; Pavla Paterová; Lucie Navrátilová; František Trejtnar; Vladimír Kubíček; Jiří Kuneš; Martin Doležal; Jan Zitko
Journal:  Molecules       Date:  2017-03-21       Impact factor: 4.411

4.  Underestimated pyrazinamide resistance may compromise outcomes of pyrazinamide containing regimens for treatment of drug susceptible and multi-drug-resistant tuberculosis in Tanzania.

Authors:  Saumu Pazia Juma; Athanasia Maro; Suporn Pholwat; Stellah G Mpagama; Jean Gratz; Alphonse Liyoyo; Eric R Houpt; Gibson S Kibiki; Blandina T Mmbaga; Scott K Heysell
Journal:  BMC Infect Dis       Date:  2019-02-07       Impact factor: 3.090

Review 5.  Application of metabolomics to drug discovery and understanding the mechanisms of action of medicinal plants with anti-tuberculosis activity.

Authors:  Naasson Tuyiringire; Deusdedit Tusubira; Jean-Pierre Munyampundu; Casim Umba Tolo; Claude M Muvunyi; Patrick Engeu Ogwang
Journal:  Clin Transl Med       Date:  2018-10-01

6.  In situ formation of steroidal supramolecular gels designed for drug release.

Authors:  Hana Bunzen; Erkki Kolehmainen
Journal:  Molecules       Date:  2013-03-25       Impact factor: 4.411
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.